STOCK TITAN

Cronos Group Inc. to Speak at the 38th Annual ROTH Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Cronos Group (NASDAQ: CRON) announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 38th Annual ROTH Conference on Monday, March 23, 2026 at 11:30 AM PDT.

A live webcast will be available via the company’s Investors site at https://ir.thecronosgroup.com/events-presentations, allowing investors to watch the presentation in real time.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Figures

Conference edition: 38th Annual Presentation time: 11:30 AM PDT Conference date: March 23, 2026
3 metrics
Conference edition 38th Annual ROTH Conference referenced in the announcement
Presentation time 11:30 AM PDT Scheduled speaking time on March 23, 2026
Conference date March 23, 2026 Date of management presentation

Market Reality Check

Price: $2.51 Vol: Volume 1,203,131 is close...
normal vol
$2.51 Last Close
Volume Volume 1,203,131 is close to the 20-day average of 1,183,259 (relative 1.02x). normal
Technical Shares at $2.51 are trading slightly above the 200-day MA of $2.45 and about 26.82% below the 52-week high.

Peers on Argus

Peers show mixed moves (e.g., TLRY -1.57%, AKBA +3.55%), while CRON is up 0.4%, ...

Peers show mixed moves (e.g., TLRY -1.57%, AKBA +3.55%), while CRON is up 0.4%, indicating a stock-specific, modest move rather than a coordinated sector rotation.

Historical Context

5 past events · Latest: Feb 26 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Feb 26 Earnings results Positive -3.6% Reported record Q4 and full-year 2025 revenue and positive adjusted EBITDA.
Feb 17 Product launch Positive +1.9% Launched Spinach PUFFERZ™ all-in-one vape with high THC content.
Feb 12 Conference call notice Neutral -1.5% Announced date and time for Q4 and full-year 2025 earnings call.
Feb 02 Market expansion Positive +0.0% Launched premium Lord Jones® brand into the Israeli medical cannabis market.
Dec 09 Acquisition announcement Positive +8.9% Announced definitive deal to acquire CanAdelaar, leading Dutch adult-use operator.
Pattern Detected

Recent positive strategic and financial updates often produced mixed price reactions, with strong moves mainly around acquisition news, while product launches and brand expansions saw smaller or flat responses.

Recent Company History

Over the last six months, Cronos reported strong 2025 results with net revenue of $146.6M and adjusted EBITDA of $10.1M, yet shares fell about 3.61% afterward. Product launches like Spinach PUFFERZ™ and the Lord Jones® expansion into Israel generated modest to flat moves. The announced CanAdelaar acquisition in the Netherlands drove an 8.91% gain, standing out as the most impactful catalyst. Compared with these events, today’s conference appearance is a routine investor-relations update.

Market Pulse Summary

This announcement highlights Cronos’s participation in the 38th Annual ROTH Conference on March 23, ...
Analysis

This announcement highlights Cronos’s participation in the 38th Annual ROTH Conference on March 23, 2026, giving management another venue to communicate strategy and performance. In recent months, the company reported record $146.6M in 2025 revenue, positive adjusted EBITDA of $10.1M, and advanced its international footprint through the CanAdelaar deal and brand launches. Investors may watch for any new operational or financial details shared during the presentation.

AI-generated analysis. Not financial advice.

TORONTO, March 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 38th Annual ROTH Conference on Monday, March 23, 2026, at 11:30 AM PDT.

A live webcast will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations.

About Cronos Group Inc.
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS®, LIT™ and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Mr. Gorenstein’s intention to speak at the 38th Annual Roth Conference and Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Investor Relations Contact:
Harrison Aaron
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com


FAQ

When will Cronos Group (CRON) speak at the 38th Annual ROTH Conference?

Cronos Group will speak on Monday, March 23, 2026 at 11:30 AM PDT. According to Cronos, Mike Gorenstein, Chairman, President and CEO, is scheduled to present and answer investor questions during that time window.

How can investors watch the Cronos Group (CRON) presentation at the ROTH Conference?

Investors can watch via a live webcast on the company’s Investors site. According to Cronos, the webcast will be available at https://ir.thecronosgroup.com/events-presentations for real-time viewing and replay.

Who from Cronos Group (CRON) will present at the ROTH Conference on March 23, 2026?

Mike Gorenstein, Chairman, President and CEO, will present at the conference. According to Cronos, he will represent the company and deliver remarks at the scheduled 11:30 AM PDT session.

What topics will Cronos Group (CRON) cover in the ROTH Conference presentation?

The announcement notes a company presentation but does not list specific topics. According to Cronos, the session will feature remarks by the CEO; investors should view the webcast for full details and any Q&A.

Will the Cronos Group (CRON) webcast from the ROTH Conference be available after the event?

The company indicates a live webcast will be available on its Investors site; archived access is likely but not guaranteed. According to Cronos, viewers should check https://ir.thecronosgroup.com/events-presentations for replay availability.
Cronos Group

NASDAQ:CRON

View CRON Stock Overview

CRON Rankings

CRON Latest News

CRON Latest SEC Filings

CRON Stock Data

943.84M
193.91M
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
STAYNER